In the present study, we demonstrated for the first time the efficacy of mesenchymal stem cells expressing TRAIL (MSC-TRAIL) against specific CD133+ CSCs isolated from NSCLC cell lines. The gene discussed is PROM1; the disease is non-small cell lung carcinoma.